NewEdge Advisors’s OnKure Therapeutics OKUR Stock Holding History

NewEdge Advisors’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,551	Closed	-$184K	–	4416
2026 Q1	$184K	Buy	+44,551	New	+$138K	﹤0.01%	2616

Other funds holding OKUR

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NewEdge Advisors's OKUR Position: Q2 2026 in Review

NewEdge Advisors sold out of OnKure Therapeutics (OKUR) in Q2 2026, closing a stake of 44,551 shares — an estimated $184K sold.

NewEdge Advisors first reported a position in OKUR in Q1 2026 and held it in 1 quarter. The position peaked at $184K in Q1 2026. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

NewEdge Advisors reported no remaining OnKure Therapeutics position as of Q2 2026 after selling out during the quarter.
NewEdge Advisors sold 44,551 OnKure Therapeutics shares in Q2 2026, an estimated $184K.
NewEdge Advisors first reported a position in OnKure Therapeutics in Q1 2026 and held it in 1 quarter.
NewEdge Advisors's OnKure Therapeutics position peaked at $184K in Q1 2026.
75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.